Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden-Harris administration wants to expand coverage of anti-obesity medications in the Medicare and Medicaid programs.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Obesity is associated with increased odds of mood and anxiety disorders, including more serious mental health conditions such as schizophrenia and bipolar disease.

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

The Biden administration is proposing to cover drugs like Ozempic, which is used to treat heart disease, diabetes and obesity ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

Popular weight-loss drugs like Wegovy or Ozempic would be covered by Medicare or Medicaid under a newly-proposed rule by the ...

“Our Medicare and Medicaid populations are some of the most at-risk and they do not have access to any anti-obesity ...

I suspect that the cost of this single executive action will end up exceeding all the savings that DOGE generates put ...

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...